3篇
您的检索式：作者名="XiaofeiSun"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Training Need Analysis Based on Competencies and Application显示文摘 | Bin He XiaofeiSun | 2004 | Enterprise Economy2004，，1： | 1 |
| 2 | Treatment of childhood cancer in China:Current status and future direction显示文摘Introduction China has a population of 1.3 billion and 16.6%of the population(212 million)is below age of 15 years according to the sixth national census in 2010.1 Chinese National Central Cancer Registry(NCCR)collected data from 219 cancer registries distributed in different parts of China.In 2010 data from NCCR reported that childhood cancer comprised approximately 0.6%of all cancers.In a recent study analyzed data from 145 cancer registries in China,the age-standardized incidence rate of childhood cancer was 87.1 per million.The top five commonest childhood cancers were leukemia(35.6 per million),central nervous system(CNS)tumor(15.0 per million),lymphoma(6.4 per million),bone cancer(4.4 per million)and kidney cancer(3.7 per million).2 The incidence is lower than western countries but similar to those reported by other low-middle income countries.The reasons for lower incidence of childhood cancer may be related to incomplete data collection.In China,there is a large floating population,221 million,who were not permanent residents in locations they worked and might not be included in the city registration.The projected number of new cases of childhood cancer in 0-14 years is 22875,and new cases of leukemia projected to be 8943 in 2015.It is important to have accurate data on incidence and survival that will help the government in policy making on health care delivery. | Chi-kong Li Jingyan Tang Huyong Zheng Jianpei Fang XiaofeiSun | 2020 | Pediatric Investigation2020，4，3： | 1 |
| 3 | Treatment of Hodgkin's Disease with Chemotherapy Based- Regimens: Long-term Follow-up Results with 295 Patients显示文摘OBJECTIVE Hodgkin's disease (HD) is a chemo and radio-sensitive hematologic malignancy. At the present time, improvement of its cure rate, reduction of its long-term detrimental effects, and maintenance of a good quality of life are the major concerns in the treatment of HD. In this study the results of a long -term follow-up from our cancer center was analyzed retrospectively in terms of efficacy and collateral side effects. METHODS The results were analyzed for 295 patients with histologicallyverified HD who were treated from 1970 to 2000, especially 182 patients treated from 1980 to 2000. Multivariant analysis (COX model ) was employed to elucidate the prognostic determinants. RESULTS The 5, 10 and 20-year survival for 295 patients with HD were 63.5%, 55.8% and 47.1% respectively with a median survival time of 172 months (28-352 months ). The median follow-up time was 43 months (17-352 months). The 5, 10 and 20 years overall survival and disease-free survival were 79.6%, 74.5%, 66.8% and 74.5% ,69.4%, 69.4% respectively for patients treated by regular chemotherapy and radiotherapy from 1980 to 2000. The incidence of late toxicities was low. An age of≥45 years, B symptoms and stage Ⅲ / Ⅳ were the main prognostic determinants (P=0.000, P=0.035 and P=0.047) in this clinical study. Stage Ⅰ/Ⅱ and nodularsclerosis were favorable factors in comparison with stages Ⅲ/Ⅳ and other histologic subtypes. CONCLUSIONS A chemotherapy-predominant modality plays an important role in the treatment of HD with promising long-term survival and fewer late toxicities. Further investigation for this simplified convenient comprehensive therapy is warranted. | HuiqiangHuang QingqingCai XubingLin YuhongLi GuangchuanXu LiZhang YouiianHe XiaofeiSun ZongmeiZhou DonggangLiu RuihuoXu TongyuLin XiaoyuTeng MaozhenLiu YisunSu WenqiJiang ZhongzhenGuang | 2004 | Chinese Journal of Clinical Oncology2004，1，3： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员